Please note that any information that you supply is protected by our Privacy Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
|
It has been known for over 80 years that ultrasound can have interesting effects on crystallization, but the absence of proven scale up equipment led the technology to be considered an academic curiosity. However, recent advances have made Prosonix unique sonocrystallization technology not only feasible, but preferable over historic processing methods for a wide range of crystallization operations.
Prosonitron® Technology has been successfully tested by multiple Pharmaceutical companies worldwide and was selected by Pfizer Manufacturing Group in Ringaskiddy Ireland for use in their key new Product Launch Facility. This White Paper discusses the true ‘scalability’ of Prosonix technologies and why Prosonix is the de-facto partner of choice for commercial scale Sonocrystallization.